Literature DB >> 6177658

Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.

A D Osterhaus, A L van Wezel, B van Steenis, G A Drost, T G Hazendonk.   

Abstract

Murine lymphocyte hybridomas which produce neutralizing or non-neutralizing monoclonal antibodies to different type 1, 2 or 3 poliovirus strains were isolated. The majority of these monoclonal antibodies reacted with antigenic determinants present on different poliovirus strains of the same type. However, hybridomas producing monoclonal antibodies specific for each of the three Sabin vaccine strains were also generated.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6177658     DOI： 10.1159/000149270

Source DB:  PubMed          Journal:  Intervirology        ISSN： 0300-5526            Impact factor:   1.763


  12 in total

1.  Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.

Authors:  M Chow; R Yabrov; J Bittle; J Hogle; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Detection of tomato spotted wilt virus using monoclonal antibodies and riboprobes.

Authors:  C Huguenot; G van den Dobbelsteen; P de Haan; C A Wagemakers; G A Drost; A D Osterhaus; D Peters
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture.

Authors:  G Edevåg; B Wahren; A D Osterhaus; V A Sundqvist; M Granström
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

4.  Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes.

Authors:  J C de Jong; K Bijlsma; A G Wermenbol; M W Verweij-Uijterwaal; H G van der Avoort; D J Wood; A S Bailey; A D Osterhaus
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

5.  Differentiation of vaccine and wild-type polioviruses using polymerase chain reaction and restriction enzyme analysis.

Authors:  B Schweiger; E Schreier; B Böthig; J M López-Pila
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.

Authors:  J V Hughes; L W Stanton; J E Tomassini; W J Long; E M Scolnick
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.

Authors:  M Ferguson; D I Magrath; P D Minor; G C Schild
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

8.  Molecular cloning and expression of Treponema pallidum DNA in Escherichia coli K-12.

Authors:  J D van Embden; H J van der Donk; R V van Eijk; H G van der Heide; J A de Jong; M F van Olderen; A B Osterhaus; L M Schouls
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

9.  Problems of live virus vaccine-associated poliomyelitis a paralytic case with isolation of all three poliovirus types.

Authors:  T Mertens; W Schürmann; J Kruppenbacher; K Rheingans; K Kellermann; G Maass; H J Eggers
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

10.  Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry.

Authors:  S Zolla-Pazner; J O'Leary; S Burda; M K Gorny; M Kim; J Mascola; F McCutchan
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.